Joanna R. Kingery

Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients

James E. Tisdale, Heather A. Jaynes, Joanna R. Kingery et al. · Circulation Cardiovascular Quality and Outcomes · 2013 · 373 citations · Full text

Effectiveness of a Clinical Decision Support System for Reducing the Risk of QT Interval Prolongation in Hospitalized Patients

James E. Tisdale, Heather A. Jaynes, Joanna R. Kingery et al. · Circulation Cardiovascular Quality and Outcomes · 2014 · 88 citations · Full text

Prevalence of QT Interval Prolongation in Patients Admitted to Cardiac Care Units and Frequency of Subsequent Administration of QT Interval-Prolonging Drugs

James E. Tisdale, Heather A. Wroblewski, Brian R. Overholser et al. · Drug Safety · 2012 · 82 citations

Heart Failure, Cardiac Anaesthesia, Cardiovascular Disease +12

High Risk of QT Interval Prolongation and Torsades de Pointes Associated with Intravenous Quinidine Used for Treatment of Resistant Malaria or Babesiosis

Heather A. Wroblewski, Richard J. Kovacs, Joanna R. Kingery et al. · Antimicrobial Agents and Chemotherapy · 2012 · 25 citations · Full text

Therapeutic Drug Monitoring, Antiparasitic Agent, Experienced Tdp +11

Enhanced Sensitivity to Drug‐Induced QT Interval Lengthening in Patients With Heart Failure Due to Left Ventricular Systolic Dysfunction

James E. Tisdale, Brian R. Overholser, Heather A. Wroblewski et al. · The Journal of Clinical Pharmacology · 2011 · 22 citations · Full text

Heart Failure, Cardiovascular Pharmacology, Pharmacotherapy +16